Eye Health

Age-related macular degeneration (ARMD) is the most common cause of blindness today. The disease leads to a gradual loss of sharp vision, making everyday activities increasingly problematic.

ARMD is a disease of the retina, which is the tissue in the human body with the highest concentration of DHA. It has been shown that people with a regular intake of seafood containing significant amounts of the Omega-3 fatty acid DHA have a lower risk of developing ARMD than those who do not eat fish.

Scientists believe that DHA can alleviate symptoms in patients with ARMD, and EPAX 1050 TG is currently being used in two ongoing clinical studies of patients with ARMD.


Click here to see articles about Omega-3 and Eye Health

 
 

EPAX 1050 TG

60 mg/g EPA
430 mg/g DHA

EPAX 1050 TG Specification
 EPAX 1050 TG Nutritional values

 

 
 
EPAX News & Events

Trygg Pharma AS has acquired 100 percent of the shares in EPAX AS

AALESUND, Norway (Sept. 03, 2010) — Trygg Pharma AS, a company jointly owned by Aker BioMarine ASA, a Norwegian biotechnology company, and Lindsay Goldberg, a New York-based investment fund, has acquired 100 percent of the shares in EPAX AS from Austevoll Seafood ASA. EPAX AS is a world-leading supplier of concentrated, marine-derived omega-3 formulas that target specific health conditions.

Read press release



 
 

Epax Unveils Latest Study At Issfal 2010

Leading Omega-3 supplier, EPAX AS, will present results from studies related to the treatment and prevention of metabolic syndrome and Type 2 Diabetes at the ISSFAL1 conference which runs from 29th May – 2nd June in Maastricht, Netherlands.

Read press release

 
 

EPAX invites you to explore our enviromental stewardship policy


www.epax.com/ecovision

 
 
EPAX AS
PO Box 2047
NO-6028 Aalesund, Norway

Site Map    •    Disclaimer

© Copyright 2008  EPAX AS

Tlf: +47 70 13 59 60
Fax: +47 70 13 59 61
E-mail: epax@epax.com
sales@epax.com